HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.

Abstract
Cutaneous leishmaniasis is a sand fly-transmitted disease characterized by skin ulcers that carry significant scarring and social stigmatization. Over the past years, there has been cumulative evidence that immunity to specific sand fly salivary proteins confers a significant level of protection against leishmaniasis. In this study, we used an attenuated strain of Listeria monocytogenes as a vaccine expression system for LJM11, a sand fly salivary protein identified as a good vaccine candidate. We observed that mice were best protected against an intradermal needle challenge with Leishmania major and sand fly saliva when vaccinated intravenously. However, this protection was short-lived. Importantly, groups of vaccinated mice were protected long term when challenged with infected sand flies. Protection correlated with smaller lesion size, fewer scars, and better parasite control between 2 and 6 weeks postchallenge compared to the control group of mice vaccinated with the parent L. monocytogenes strain not expressing LJM11. Moreover, protection correlated with high numbers of CD4(+), gamma interferon-positive (IFN-γ(+)), tumor necrosis factor alpha-positive/negative (TNF-α(+/-)), interleukin-10-negative (IL-10(-)) cells and low numbers of CD4(+) IFN-γ(+/-) TNF-α(-) IL-10(+) T cells at 2 weeks postchallenge. Overall, our data indicate that delivery of LJM11 by Listeria is a promising vaccination strategy against cutaneous leishmaniasis inducing long-term protection against ulcer formation following a natural challenge with infected sand flies.
AuthorsDelbert S Abi Abdallah, Alan Pavinski Bitar, Fabiano Oliveira, Claudio Meneses, Justin J Park, Susana Mendez, Shaden Kamhawi, Jesus G Valenzuela, Hélène Marquis
JournalInfection and immunity (Infect Immun) Vol. 82 Issue 7 Pg. 2736-45 (Jul 2014) ISSN: 1098-5522 [Electronic] United States
PMID24733091 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2014, American Society for Microbiology. All Rights Reserved.
Chemical References
  • Insect Proteins
  • Leishmaniasis Vaccines
  • Salivary Proteins and Peptides
  • Vaccines, Synthetic
Topics
  • Animals
  • Bites and Stings (immunology, parasitology)
  • Ear, External (immunology, parasitology)
  • Insect Proteins (immunology)
  • Insect Vectors (parasitology)
  • Leishmania major (immunology)
  • Leishmaniasis Vaccines (immunology)
  • Leishmaniasis, Cutaneous (prevention & control)
  • Listeria monocytogenes
  • Mice
  • Mice, Inbred C57BL
  • Psychodidae (physiology)
  • Salivary Proteins and Peptides (immunology)
  • T-Lymphocytes (classification)
  • Vaccines, Synthetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: